Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy"
Post a Comment